Medicare Enrolled

Dr. Qing Ni, M.D.

Neurology · Newnan, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
60 OAK HILL BLVD, Newnan, GA 30265
7706838637
In practice since 2006 (20 years)
NPI: 1295765311 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ni

Dr. Qing Ni is a neurology specialist in Newnan, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ni performed 2,265 Medicare services across 1,425 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ni received a total of $42,058 from 85 pharmaceutical and/or device companies across 1339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in GA $42,058 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,265
Medicare services
Top 18% in GA for neurology
1,425
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
857 $87 $267
Virtual check-in for established patient
A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in.
495 $10 $40
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
235 $71 $351
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
161 $119 $386
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
70 $155 $710
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $63 $157
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
45 $90 $383
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
32 $23 $104
Psychological test administration, each additional 30 minutes
A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time.
31 $24 $89
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
29 $308 $798
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
29 $199 $783
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
29 $92 $245
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
28 $211 $930
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
27 $53 $173
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
24 $94 $556
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
23 $64 $358
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
23 $89 $326
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $127 $325
New patient office visit, complex (60-74 min) 15 $165 $435
CT scan of head/brain, without contrast
A CT scan uses X-rays to create detailed images of the head or brain without the use of contrast dye.
14 $31 $111
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
13 $129 $599
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
11 $182 $790
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$42,058
Total received (2018-2024)
Avg $6,008/year across 7 years
Top 10% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
1,339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,718 (54.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,582 (34.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,757 (11.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,208
2023
$3,736
2022
$9,964
2021
$15,976
2020
$2,370
2019
$2,360
2018
$3,443

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$448
MDD US Operations, LLC
$335
Lundbeck LLC
$306
PFIZER INC.
$254
Neurocrine Biosciences, Inc.
$234
JAZZ PHARMACEUTICALS INC.
$228
Novartis Pharmaceuticals Corporation
$215
Teva Pharmaceuticals USA, Inc.
$202
Neurelis, Inc.
$182
SK Life Science, Inc.
$175
HARMONY BIOSCIENCES LLC
$168
ACADIA Pharmaceuticals Inc
$165
Eisai Inc.
$160
ABBVIE INC.
$131
EMD Serono, Inc.
$125
Lilly USA, LLC
$124
SCILEX PHARMACEUTICALS INC.
$104
ARGENX US, INC.
$95
Alexion Pharmaceuticals, Inc.
$84
Biogen, Inc.
$67
Kyowa Kirin, Inc.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$54
Grifols USA, LLC
$54
CSL Behring
$53
ANI Pharmaceuticals, Inc.
$42
Azurity Pharmaceuticals, Inc.
$36
Harmony Biosciences Llc
$30
Otsuka America Pharmaceutical, Inc.
$21
Genentech USA, Inc.
$18
Mallinckrodt Hospital Products Inc.
$18
TG Therapeutics, Inc.
$16
Top 3 companies account for 25.9% of 2024 payments
All-time payments by company (2018-2024) ›
Biohaven Pharmaceuticals, Inc.
$12,052
SK Life Science, Inc.
$5,518
ABBVIE INC.
$2,998
UCB, Inc.
$1,632
Novartis Pharmaceuticals Corporation
$840
Teva Pharmaceuticals USA, Inc.
$828
Sunovion Pharmaceuticals Inc.
$825
Amgen Inc.
$742
Avanir Pharmaceuticals, Inc.
$724
Supernus Pharmaceuticals, Inc.
$652
Lilly USA, LLC
$638
JAZZ PHARMACEUTICALS INC.
$632
UPSHER-SMITH LABORATORIES LLC
$582
Upsher-Smith Laboratories LLC
$574
EMD Serono, Inc.
$544
Biogen, Inc.
$529
Neurelis, Inc.
$525
Lundbeck LLC
$519
Scilex Pharmaceuticals Inc.
$519
Eisai Inc.
$518
GENZYME CORPORATION
$505
Alexion Pharmaceuticals, Inc.
$493
MDD US Operations, LLC
$490
PFIZER INC.
$483
Greenwich Biosciences, Inc.
$456
Neurocrine Biosciences, Inc.
$407
ACADIA Pharmaceuticals Inc
$392
Kyowa Kirin, Inc.
$342
AbbVie Inc.
$321
Allergan Inc.
$307
Genentech USA, Inc.
$306
Adamas Pharmaceuticals, Inc.
$285
Amneal Pharmaceuticals LLC
$257
US WorldMeds, LLC
$257
ARGENX US, INC.
$233
AstraZeneca Pharmaceuticals LP
$231
Otsuka America Pharmaceutical, Inc.
$223
Promius Pharma LLC
$210
Allergan, Inc.
$191
Azurity Pharmaceuticals, Inc.
$190
Biohaven Pharmaceutical Holding Company Ltd.
$188
ANI Pharmaceuticals, Inc.
$184
HARMONY BIOSCIENCES LLC
$168
CSL Behring
$166
Currax Pharmaceuticals LLC
$163
EISAI INC.
$162
Grifols USA, LLC
$135
Harmony Biosciences LLC
$126
Akcea Therapeutics, Inc.
$126
Janssen Pharmaceuticals, Inc
$117
Impax Laboratories, Inc.
$114
Mallinckrodt Hospital Products Inc.
$111
Acorda Therapeutics, Inc
$109
SCILEX PHARMACEUTICALS INC.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$103
Avion Pharmaceuticals
$94
Arbor Pharmaceuticals, Inc.
$78
Bausch Health US, LLC
$72
IMPEL PHARMACEUTICALS INC.
$68
Neuronetics, Inc.
$63
ARBOR PHARMACEUTICALS, INC.
$61
Mallinckrodt LLC
$51
Vertical Pharmaceuticals, LLC
$46
Vanda Pharmaceuticals Inc.
$40
AQUESTIVE THERAPEUTICS, INC.
$36
Corium, LLC
$31
GE HEALTHCARE
$30
Harmony Biosciences Llc
$30
Zyla Life Sciences
$30
Alnylam Pharmaceuticals Inc.
$30
BANNER LIFE SCIENCES, LLC
$25
ASSERTIO THERAPEUTICS, Inc.
$23
Xeris Pharmaceuticals, Inc.
$20
Horizon Therapeutics plc
$20
Alfasigma USA, Inc.
$19
Zyla Life Sciences, Inc.
$17
TG Therapeutics, Inc.
$16
Aprecia Pharmaceuticals, LLC
$15
LivaNova USA, Inc.
$15
CATALYST PHARMACEUTICALS, INC.
$15
Advanced Respiratory, Inc
$14
Almatica Pharma LLC
$14
Shire North American Group Inc
$14
Electronic Waveform Lab, Inc.
$12
Egalet US Inc
$11
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FORTEO · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HETLIOZ · HORIZANT · HYQVIA · Hetlioz · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · Life 2000 Ventilation System · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONPATTRO · ONZETRA XSAIL · ONZETRA Xsail · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · Spritam · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · Xadago · ZEMBRACE SYMTOUCH · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in GA.

Looking for a neurology specialist in Newnan?
Compare neurologists in the Newnan area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
18
Per 100K population
12.0
County median income
$94,142
Nearest hospital
PIEDMONT NEWNAN HOSPITAL, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ni is a clinical cardiology specialist, with above-average Medicare volume (top 18% in GA), with low-engagement industry engagement in the top 10% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ni experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ni performed 857 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ni receive payments from pharmaceutical companies?
Yes. Dr. Ni received a total of $42,058 from 85 companies across 1,339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ni's costs compare to other neurologists in Newnan?
Dr. Ni's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →